...
首页> 外文期刊>Journal of pharmacological sciences. >Losartan Normalizes Endothelium-Derived Hyperpolarizing Factor–Mediated Relaxation by Activating Ca2+-Activated K+ Channels in Mesenteric Artery From Type 2 Diabetic GK Rat
【24h】

Losartan Normalizes Endothelium-Derived Hyperpolarizing Factor–Mediated Relaxation by Activating Ca2+-Activated K+ Channels in Mesenteric Artery From Type 2 Diabetic GK Rat

机译:氯沙坦通过激活2型糖尿病GK大鼠肠系膜动脉中的Ca2 +激活的K +通道,使内皮源性超极化因子介导的舒张正常化。

获取原文
           

摘要

References(56) Cited-By(11) Ca2+-activated K+ (KCa) channels are important for endothelium-derived hyperpolarizing factor (EDHF) signaling. Since treatment with angiotensin II receptor blockers (ARBs) improves vasculopathies in type 2 diabetic patients, we asked whether the EDHF-type relaxation and its associated KCa channels [small (SKCa)–, intermediate (IKCa)–, and large (BKCa)–conductance channels] are abnormal in mesenteric arteries isolated from Goto-Kakizaki (GK) rats at the chronic stage of type 2 diabetes (34 – 38 weeks) and whether an ARBs (losartan, 25 mg · kg−1 · day−1 for 2 weeks) might correct these abnormalities. Although the acetylcholine chloride–induced EDHF-type relaxation in mesenteric arteries from GK rats was reduced versus the Wistar controls, it was significantly restored by losartan treatment. The SKCa-blocker apamin or the IKCa-blocker 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34) inhibited such relaxations in the losartan-treated or -untreated Wistar groups and in the losartan-treated GK group, but not in the losartan-untreated GK group. The BKCa-blocker iberiotoxin had a significant inhibitory effect in only one of these groups, the losartan-treated GK. The relaxations induced by the SKCa/IKCa activator NS309 and the BKCa activator NS1619, which were impaired in GK rats, were normalized by losartan treatment. We conclude that losartan improves EDHF-type relaxation in GK rats at least partly by normalizing SKCa/IKCa activities and increasing BKCa activity.
机译:参考文献(56)被Cy-By(11)激活的Ca2 +激活的K +(KCa)通道对于内皮衍生的超极化因子(EDHF)信号很重要。由于使用血管紧张素II受体阻滞剂(ARBs)的治疗可改善2型糖尿病患者的血管病变,因此我们询问EDHF型弛豫及其相关的KCa通道[小(SKCa)–,中(IKCa)–和大(BKCa)–电导通道]在2型糖尿病的慢性期(34 – 38周)从Goto-Kakizaki(GK)大鼠分离的肠系膜动脉中异常,并且是否存在ARB(氯沙坦,25 mg·kg-1·第1天= 2)个星期)可能会纠正这些异常情况。尽管与Wistar对照相比,乙酰胆碱氯化物引起的GK大鼠肠系膜动脉EDHF型松弛减少,但氯沙坦治疗可明显恢复。在氯沙坦治疗或未治疗的Wistar组和氯沙坦治疗的GK组中,SKCa受体阻滞剂apamin或IKCa受体阻滞剂1-[((2-氯苯基)二苯甲基] -1H-吡唑(TRAM-34)抑制了这种松弛,但未接受未经氯沙坦治疗的GK组。 BKCa受体阻滞剂纤毛毒素仅在氯沙坦治疗的GK这一组中具有显着的抑制作用。通过氯沙坦治疗使在GK大鼠中受损的SKCa / IKCa激活剂NS309和BKCa激活剂NS1619诱导的弛豫正常化。我们得出的结论是,氯沙坦至少可以通过正常化SKCa / IKCa活性和增加BKCa活性来改善GK大鼠的EDHF型松弛。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号